Canopy Growth Corp vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Canopy Growth Corp trades at $1 (market cap $421.10M), while YieldMax TSLA Option Income Strategy ETF trades at $21.64. Which is the better fit depends on your goals.
| CGC | TSLY | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.92 | $48.25 |
52-Week Low | $0.86 | $20.49 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.
CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.
TSLY trades at $21.62, down 0.51% today, with a bearish technical outlook per moving averages and mixed oscillators. The ETF maintains high dividend distributions, with recent payouts ranging from $0.21 to $0.52 weekly, but faces capped upside risk due to its option income strategy structure. Recent news highlights concerns over missed Tesla rallies and volatility shifts, impacting sentiment.
Outlook is cautious due to structural limitations in capturing Tesla's gains, with risks including volatility dependency and competitive ETF strategies. The high yield attracts income seekers, but total return potential may be constrained if Tesla appreciates significantly, warranting careful risk assessment for equity-focused investors.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →